Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 11,399 | 13,817 | 5,425 | 3,970 | 4,574 |
| Cost of Goods | 3,545 | 5,508 | 4,632 | 2,820 | 2,953 |
| Gross Profit | 7,854 | 8,309 | 793 | 1,151 | 1,621 |
| Operating Expenses | 22,744 | 23,576 | 14,485 | 18,013 | 20,263 |
| Operating Income | -14,345 | -14,759 | -13,060 | -16,043 | -17,689 |
| Interest Expense | 1,118 | 1,045 | 18 | 40 | 0 |
| Other Income | 426 | 408 | -4,835 | 5,099 | 840 |
| Pre-tax Income | -15,038 | -15,395 | -17,913 | -10,984 | -16,849 |
| Income Tax | -2,015 | -2,999 | -1,498 | -2,618 | -1,859 |
| Net Income Continuous | -13,023 | -12,396 | -16,415 | -8,366 | -14,989 |
| Net Income | $-13,023 | $-12,396 | $-16,415 | $-8,366 | $-14,989 |
| EPS Basic Total Ops | -0.36 | -0.35 | -0.45 | -0.25 | -0.50 |
| EPS Basic Continuous Ops | -0.36 | -0.34 | -0.46 | -0.25 | -0.50 |
| EPS Diluted Total Ops | -0.36 | -0.35 | -0.45 | -0.25 | -0.50 |
| EPS Diluted Continuous Ops | -0.36 | -0.34 | -0.46 | -0.25 | -0.50 |
| EBITDA(a) | $-14,193 | $-14,596 | $-12,865 | $-15,926 | $-17,555 |